Obstetrics & Gynecology Science

Gynecologic Oncology
Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study: Ekasak Thiangphak, Kittinun Leetanaporn, Rakchai Buhachat; Obstet Gynecol Sci. 2023;66(5):407-416. Published online July 19, 2023; DOI: https://doi.org/10.5468/ogs.23119; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand: Kulisara Nanthamongkolkul, Pacharadol Taweerat, Ingporn Jiamset; Obstet Gynecol Sci. 2023;66(3):198-207. Published online March 23, 2023; DOI: https://doi.org/10.5468/ogs.22262; Full text PubReader ePub Crossref - TDM PDF

Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma: Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat; Obstet Gynecol Sci. 2022;65(5):459-467. Published online July 29, 2022; DOI: https://doi.org/10.5468/ogs.22102
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry: Hyeong In Ha, Ha Kyun Chang, Soo Jin Park, Jiwon Lim, Young-Joo Won, Myong Cheol Lim; Obstet Gynecol Sci. 2021;64(5):444-453. Published online August 17, 2021; DOI: https://doi.org/10.5468/ogs.21116 Correction in: Obstet Gynecol Sci 2022;65(4):384
Cited By 34; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer: Emre Günakan, Yusuf Aytaç Tohma, Latife Atasoy Karakaş, Hüseyin Akıllı, Asuman Nihan Haberal, Ali Ayhan; Obstet Gynecol Sci. 2020;63(4):464-469. Published online June 19, 2020; DOI: https://doi.org/10.5468/ogs.19204
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis: Jinlan Piao, Hyun Ji Lim, Maria Lee; Obstet Gynecol Sci. 2020;63(3):346-356. Published online March 24, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.346
Cited By 9; Full text PubReader ePub Crossref - TDM PDF

Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases: E Sun Paik, Jae Hong Kang, Jihye Kim, Yeon-Joo Lee, Chel Hun Choi, Tae-Joong Kim, Byoung-Gie Kim, Duk-Soo Bae, Jeong-Won Lee; Obstet Gynecol Sci. 2019;62(2):103-111. Published online February 12, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.2.103
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

Gynecologic Oncology
Effect of tibolone on the survival of early stage cervical adenocarcinoma patients: Seung-Ho Lee, Yoon-Jin Cho, Kyung-Joo Cho, Mee-Hyang Ko, Sun-Young Jung, Seung-Joo Chon, So-Yi Lim, Kwang-Beom Lee; Obstet Gynecol Sci. 2018;61(5):584-589. Published online August 7, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.5.584
Cited By 2; Full text PubReader Crossref - TDM PDF

Gynecologic Oncology
Prognostic value of preoperative lymphocyte-monocyte ratio in elderly patients with advanced epithelial ovarian cancer: Byung Su Kwon, Hyun Joo Lee, Juseok Yang, Yong Jung Song, Dong Soo Suh, Dong Hyung Lee, Ki Hyung Kim; Obstet Gynecol Sci. 2017;60(6):558-564. Published online October 31, 2017; DOI: https://doi.org/10.5468/ogs.2017.60.6.558
Cited By 1; Full text PubReader Crossref - TDM PDF

Gynecologic Oncology
The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients: Hyun Kyung Ryu, Ji Sun Baek, Woo Dae Kang, Seok Mo Kim; Obstet Gynecol Sci. 2015;58(5):368-376. Published online September 22, 2015; DOI: https://doi.org/10.5468/ogs.2015.58.5.368
Cited By 26; Full text PubReader Crossref - TDM PDF

Gynecologic Oncology
Krukenberg tumors of gastric origin versus colorectal origin: Yi Jo Jeung, Hee Jae Ok, Won Gyu Kim, Sung Han Kim, Tae Hwa Lee; Obstet Gynecol Sci. 2015;58(1):32-39. Published online January 16, 2015; DOI: https://doi.org/10.5468/ogs.2015.58.1.32
Cited By 23; Full text PubReader Crossref - TDM PDF

Survival outcomes and toxicity of intraoperative intraperitoneal chemotherapy in advanced epithelial ovarian cancer: Ji-Young Yoon, Yu-Jin Koo, Mi-Jung Kim, Tae-Jin Kim, Kyung-Taek Lim, Ki-Heon Lee; Obstet Gynecol Sci. 2014;57(6):484-491. Published online November 20, 2014; DOI: https://doi.org/10.5468/ogs.2014.57.6.484
Cited By 5; Full text PubReader Crossref - TDM PDF

Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer: Na-Ri Shin, Yoo-Young Lee, Seung-Hyun Kim, Chel Hun Choi, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim; Obstet Gynecol Sci. 2014;57(1):28-36. Published online January 16, 2014; DOI: https://doi.org/10.5468/ogs.2014.57.1.28
Cited By 20; Full text PubReader Crossref - TDM PDF

Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer: Tae Yeon Lee, Yi Jo Jeung, Chun Jun Lee, Heung Yeol Kim, Sung Han Kim, Won Gyu Kim; Obstet Gynecol Sci. 2013;56(1):15-21. Published online January 9, 2013; DOI: https://doi.org/10.5468/OGS.2013.56.1.15
Cited By 15; Full text PubReader Crossref - TDM PDF

Prognosis of stage IIB cervical cancer among treatment regimens: Radical hysterectomy vs. neoadjuvant chemotherapy followed by radical hysterectomy vs. concurrent chemoradiotherapy.: Young Ju Woo, Jung Mi Byun, Dae Hoon Jeong, Young Nam Kim, Su Seon Kim, Young Jin Seo, Moon Su Sung, Kyoung Bok Lee, Ki Tae Kim; Korean J Obstet Gynecol. 2012;55(12):913-919. Published online December 18, 2012; DOI: https://doi.org/10.5468/KJOG.2012.55.12.913
Cited By 1; PDF

Search